The Food and Drug Administration has approved remdesivir as the first COVID-19 treatment in the United States. Some studies have shown the antiviral drug may reduce the number of days COVID-19 patients are hospitalized, though a large World Health Organization study published last week found remdesivir fails to prevent deaths among COVID-19 patients.
Topics: